You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-Small Cell Lung Cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

Recruiting
  • Non-Small-Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Aug 25, 2023

Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Propranolol
  • Propranolol hydrochloride
  • +2 more
  • (no location specified)
Jul 31, 2023

Non Small Cell Lung Cancer Trial (TGRX-326, Crizotinib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • (no location specified)
Oct 8, 2023

NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)

Not yet recruiting
  • Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
  • tereotactic body radiotherapy
  • (no location specified)
Dec 1, 2023

NSCLC Trial in Shanghai (SI-B001, SI-B003)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 10, 2023

NSCLC Trial (V940, Pembrolizumab, Placebo)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • V940
  • +2 more
  • (no location specified)
Oct 5, 2023

Cancer Medicines in Metastatic Non-small Cell Lung Cancer in

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Oslo, Norway
    Pfizer Norway
Apr 17, 2023

Learn About Dacomitnib in Non-small Cell Lung Cancer Which Has

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Oct 4, 2023

Stage IB Non-small Cell Lung Cancer

Completed
  • Stage IB Non-Small Cell Lung Carcinoma
    • Shanghai, China
      180 Fenglin Road
    Jul 29, 2023

    NSCLC(NSCLC) Trial in Jinan (WX-0593 Tablets)

    Not yet recruiting
    • Non-Small Cell Lung Cancer(NSCLC)
    • WX-0593 Tablets
    • Jinan, Shandong, China
      Shandong Cancer Hospital and Institute
    Mar 1, 2023

    NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +

    Recruiting
    • Non-Small Cell Lung Cancer
    • +2 more
    • Befotertinib + Icotinib placebo
    • Icotinib + Befotertinib placebo
    • Beijing, China
    • +2 more
    Sep 20, 2023

    Lung Cancer Trial (exercise)

    Not yet recruiting
    • Lung Cancer
    • exercise
    • (no location specified)
    Jul 17, 2023

    Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

    Not yet recruiting
    • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    • (no location specified)
    May 8, 2023

    Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

    Recruiting
    • Nonsmall Cell Lung Cancer
    • HS-10365 capsules
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Nov 22, 2023

    NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • MK-2870
    • +2 more
    • (no location specified)
    Oct 3, 2023

    NSCLC Trial (SGN-B6A, docetaxel)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Aug 21, 2023

    EGFR Mutant Advanced NSCLC Trial (BBT-207)

    Not yet recruiting
    • EGFR Mutant Advanced Non-Small Cell Lung Cancer
    • (no location specified)
    Jun 16, 2023

    NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Crizotinib - Usual
    • Crizotinib - Study
    • Rockville, Maryland
      Medicine Invention Design, Inc. - IORG0007849
    Oct 5, 2023

    Huaier Granules in Postoperative Adjuvant Therapy for Non-small

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Huaier granule
    • Control
    • Shenyang, Liaoning, China
      Liaoning Cancer Hospital & Institute
    Oct 27, 2023

    NSCLC Trial in Suzhou (Envafolimab Injection)

    Recruiting
    • NSCLC
    • Envafolimab Injection
    • Suzhou, Jiangsu, China
      Northern Jiangsu People's Hospital
    Oct 29, 2023

    NSCLC Trial in Shanghai (BL-M02D1)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 10, 2023

    Lung Cancer Trial (Sacituzumab Govitecan, Pembrolizumab)

    Not yet recruiting
    • Lung Cancer
    • (no location specified)
    Sep 20, 2023

    Non-small Cell Lung Cancer With Central Nervous System

    Recruiting
    • Lung Cancer With Central Nervous System Metastasis
    • lung cancer with brain /leptomeningeal metastasis
    • Taipei, Taiwan
      National Taiwan University Hospital
    Sep 4, 2023

    ALK Positive NSCLC Trial in Guangzhou (Loratinib)

    Recruiting
    • ALK Positive Non-small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Guangdong Provincial Perople's Hospital
    Oct 19, 2023

    TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

    Not yet recruiting
    • Lung Cancer, Non-small Cell
    • Small Cell Lung Cancer
      • (no location specified)
      Nov 16, 2022